Vaxcyte Inc. (PCVX)
NASDAQ
Closed
Oct 19, 2026
Day's Range
63.3852 wk Range
39.87Overview - PCVX - Vaxcyte Inc.
Key Statistics
Valuation
Enterprise Value
6.99B
P/E (Trailing)
-9.99
P/E (Forward)
-7.78
PEG Ratio
-0.16
Price / Book
2.95
EV / EBITDA
-6.08
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-22.60%
Return on Equity
-36.51%
Ownership
Shares Outstanding
144.78M
Float
136.43M
Short % of Shares Outstanding
10.90%
Held by Insiders
0.49%
Held by Institutions
113.46%
Price stats
Beta
1.22
50-Day Avg
58.48
200-Day Avg
54.77
Dividends
Payout Ratio
0.00%
Analyst Consensus
11 analysts
Average price target
$ 109.00Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PCVX - Vaxcyte Inc.
Peers - PCVX - Vaxcyte Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PCVXNASDAQVaxcyte Inc.8.36BMarket Cap+38.36%52-week change-9.99P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - PCVX - Vaxcyte Inc.
About
Vaxcyte Inc. is a clinical-stage vaccine company focused on developing next-generation vaccines for bacterial infectious diseases. The company uses its proprietary cell-free protein synthesis platform to design and produce optimized protein carriers and antigens, supporting the creation of conjugate and protein-based…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
